NASDAQ · MTVAHealthcarePharmaceuticals

MetaVia financials

$1.66−0.60%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$0.00$0.00
Gross profit$0.00$0.00
Gross margin——
Operating income-$13.7M-$28.8M
Net income-$13.0M-$27.6M
Net margin——
Diluted EPS$-7.35$-39.13
EBITDA-$13.7M-$28.8M
Operating cash flow-$15.7M-$24.7M
Free cash flow-$15.7M-$24.7M
Diluted shares1.8M0.7M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$10.3M$16.0M
Short-term investments$0.00$0.00
Total debt$215.0K$361.0K
Total assets$11.1M$16.3M
Total liabilities$5.8M$8.3M
Shareholders' equity$5.3M$7.9M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology